Levodopa
Moderate
Textbook
Potentiation of levodopa's action.
Source: KDT 7e · p57
Drug reference
benserazide
Dopa decarboxylase inhibitor · Anti-parkinsonian adjunct
Dopa decarboxylase inhibitorAnti-parkinsonian adjunct
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Competes with levodopa for the catalytic binding site of the enzyme Dopa decarboxylase.
Indications
Used as an adjuvant to levodopa in Parkinson's disease
Drug interactions
Related guidelines
Coeliac disease
OTHER · Gastroenterology · 2016
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Chronic kidney disease — assessment and management
KDIGO · Nephrology · 2024
Chronic kidney disease — assessment and management
NICE · Nephrology · 2021
Diabetes management in chronic kidney disease
KDIGO · Nephrology · 2022
Ask House about benserazide
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team